EICHORPublic-registry trials using AK-D101 that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| A Phase 3 Study of Viloxazine ER Capsules in Korean Children and Adolescents With ADHD | Alvogen Korea | Attention Deficit Hyperactivity Disorder | PHASE3 | 1 |
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
